Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.
The global in vitro diagnostics (IVD) market is evolving rapidly, driven by growing demand for faster, more accessible testing across clinical and consumer settings. As healthcare systems shift toward earlier detection, personalised treatment, and decentralised care, the need for innovative diagnostics has never been greater.
Psychedelics are reshaping mental health treatment, with over 100 active psilocybin trials reflecting renewed interest after decades of stalled progress due to stigma and regulation.
The transition from IVDD to IVDR represents the most significant regulatory change for diagnostic devices in Europe in decades. With extended transition periods now in place, clinical study sponsors face both new challenges and opportunities. Understanding the evolving requirements is essential to staying compliant and keeping studies on track.
The continuous glucose monitor (CGM) has evolved far beyond its original purpose as a diabetes management tool. Recently, the FDA cleared the first over-the-counter CGM intended for anyone 18 years and older who does not use insulin, including those without diabetes who want to better understand how diet and exercise impact blood sugar levels. This landmark approval has opened new frontiers in personalized medicine, where metabolic insights drive precision health interventions.
In the dynamic landscape of life sciences, the term "CRO" is a crucial acronym that stands for Contract Research Organization. CROs are the backbone of the pharmaceutical, biotechnology, and medical device industries, offering essential services that expedite the development and validation of new drugs and medical devices. This article offers a deep dive into what a CRO is, the services it typically provides, and how it plays a pivotal role in the medical research landscape. We'll also explore how Lindus Health exemplifies the characteristics and services of a CRO.
The contract research organization (CRO) market is witnessing an unprecedented surge, with the global CRO market reaching an impressive valuation of US$56.5 billion in 2022. Expected to almost double by 2028, the CRO landscape is thriving, with research and development (R&D) expenditures and clinical trials powering the industry's growth.CROs have become indispensable players in the healthcare sector, offering a wide range of R&D services to support the clinical trial process and advance healthcare innovations. Here, we delve into the top 10 CROs that are shaping the future of healthcare, driving innovation, and accelerating R&D across the globe.
Discover the intricate link between Protein Kinase C and cancer in this comprehensive guide to targeted therapy.
Unlock the secrets of biotechnology with our comprehensive guide! From gene editing to sustainable agriculture, this article covers everything you need to know about this fascinating field.
Discover the fascinating world of immunomodulatory therapies and their impact on the immune system in nAMD.
Explore the latest advancements and top trends shaping the future of biotech and clinical research in 2024.
Discover the evolution of HER2 inhibitors in this comprehensive guide, exploring their impact on cancer treatment and the latest advancements in targeted therapy.
Discover how the future of drug development is being transformed by the revolutionary potential of AI.
Discover the impact of Companion Diagnostics (CDx) on clinical research in this comprehensive guide.
Diagnostic trials are vital to evaluate the efficacy and safety of new diagnostic methods. The faster these trials are conducted, the quicker patients can benefit from new diagnostic tools. Accelerating these trials is not just about speed, but also about maintaining the highest levels of accuracy and reliability.